関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Chloroquine | HCID 2719 | — |
| 反応物 | Mefloquine | HCID 4046 | — |
| 反応物 | Primaquine | HCID 4908 | — |
| 反応物 | Pyrimethamine | HCID 4993 | — |
| 反応物 | Cycloguanil | HCID 9049 | — |
| 反応物 | Sulfadoxine | HCID 17134 | — |
| 反応物 | Floxacrine | HCID 68708 | — |
| 反応物 | Quinine | HCID 3034034 | — |
| 生成物 | Dapsone | HCID 2955 | — |
反応手順
Depending on the type of the second antimalarial used with the tetrahydroacridones, the preferred proportions by weight used vary. When using Floxacrine in admixture with Quinine, a ratio of 1:10 to 1:160, in particular from 1:40 to 1:80; in admixture with Chloroquine from 4:1 to 1:20, in particular 2:1 to 1:8; in admixture with Mefloquine from 1:1.25 to 1:10; in admixture with Primaquine from 1:1.25 to 1:20, in particular 1:2.5 to 1:20; in admixture with Pyrimethamine from 21:1 to 1:1.5, in particular 10.4:1 to 1:1.5; in admixture with Cycloguanil from 1:35 to 1:284, in particular 1:142 to 1:284; in admixture with Trimethroprim from 1:10 to 1:80, in particular 1:40 to 1:80, in admixture with Sulfadoxine from 1:1 to 1:32, in particular 1:1 to 1:6; in admixture with Dapsone from 1:5 to 1:80, in particular 1:10 to 1:80, the best synergistic was obtained.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US04284627 |
|---|
| 出典データセット | uspto-grants-1981_08 |
|---|
| ORD ID | ord-3c822937f83f454ebc4d6fc07a5adf09 |
|---|
| 出典メモ | uspto-grants-1981_08 |
|---|